| Current understanding of an emerging role of HLA-DRB1 gene in rheumatoid arthritis–from research to clinical practice T Wysocki, M Olesińska, A Paradowska-Gorycka Cells 9 (5), 1127, 2020 | 96 | 2020 |
| Pharmacogenomics of anti-TNF treatment response marks a new era of tailored rheumatoid arthritis therapy T Wysocki, A Paradowska-Gorycka International journal of molecular sciences 23 (4), 2366, 2022 | 22 | 2022 |
| Przyczepa dynamometryczna do badań dynamicznych ogumienia W Luty VII Międzynarodowe Sympozjum IPM WAT, 1999 | 8 | 1999 |
| AHR-dependent genes and response to MTX therapy in rheumatoid arthritis patients A Wajda, E Walczuk, B Stypińska, J Lach, D Yermakovich, L Sivitskaya, ... The Pharmacogenomics Journal 21 (5), 608-621, 2021 | 2 | 2021 |
| Badania ogumienia w aspekcie bezpieczeństwa ruchu drogowego L Prochowski, T Wysocki Zeszyty Naukowe Politechniki Świętokrzyskiej. Mechanika, 49-80, 1998 | 1 | 1998 |
| NADPH oxidase expression profile and PBMC immunophenotypic changes in anti-TNF-treated rheumatoid arthritis patients T Wysocki, A Wajda, T Kmiołek, J Wroński, M Roszkowska, M Olesińska, ... Clinical Immunology 271, 110414, 2025 | | 2025 |
| Health-related quality of life impairment is equal for antiphospholipid syndrome whether primary or associated with systemic lupus erythematosus E Haladyj, A Matusiewicz, T Wysocki, M Olesinska Reumatologia 62 (4), 266, 2024 | | 2024 |
| Gene expression analysis of anti-TNF-treated rheumatoid arthritis patients reveals the links between NADPH oxidase expression profile and immunophenotypic changes in peripheral … T Wysocki, A Wajda, T Kmiołek, J Wroński, M Roszkowska, M Olesinska, ... | | 2024 |
